Vol 2, No 3 (September 12, 2013): Translational Andrology and Urology (Prostate Cancer)


Jer-Tsong Hsieh, Ganesh Raj

Review Articles

Current clinical challenges in prostate cancer
Jonathan L. Silberstein, Sumanta Kumar Pal, Brian Lewis, Oliver Sartor
Androgen receptor gene mutation, rearrangement, polymorphism
Kurtis Eisermann, Dan Wang, Yifeng Jing, Laura E. Pascal, Zhou Wang
Androgen receptor epigenetics
Changmeng Cai, Xin Yuan, Steven P. Balk
Androgen receptor genomic regulation
Hong-Jian Jin, Jung Kim, Jindan Yu
Decoding the androgen receptor splice variants
Changxue Lu, Jun Luo
Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation
Ross S. Liao, Shihong Ma, Lu Miao, Rui Li, Yi Yin, Ganesh V. Raj
Translating insights of AR signaling from mouse models
Brett S. Carver
Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
Campbell M. Grant, Natasha Kyprianou
Steroid hormone synthetic pathways in prostate cancer
Elahe A. Mostaghel
The role of microRNAs in prostate cancer progression
U-Ging Lo, Diane Yang, Jer-Tsong Hsieh
Cancer stem cells in prostate cancer
Felix Moltzahn, George N. Thalmann
Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer
Jason Wu, Dongfeng Pan, Leland W.K. Chung
Novel non-AR therapeutic targets in castrate resistant prostate cancer
Paul J. Toren, Martin E. Gleave


The focused issue “Prostate Cancer” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Jer-Tsong Hsieh and Ganesh Raj served as the unpaid Guest Editors for the focused issue.